TARS logo

Tarsus Pharmaceuticals, Inc. (TARS) Operating Expenses

Annual Operating Expenses:

$290.70M+$131.68M(+82.81%)
December 31, 2024

Summary

  • As of today, TARS annual total operating expenses is $290.70 million, with the most recent change of +$131.68 million (+82.81%) on December 31, 2024.
  • During the last 3 years, TARS annual operating expenses has risen by +$223.59 million (+333.17%).
  • TARS annual operating expenses is now at all-time high.

Performance

TARS Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSincome statement metrics

Quarterly Operating Expenses:

$124.92M+$6.31M(+5.32%)
September 30, 2025

Summary

  • As of today, TARS quarterly total operating expenses is $124.92 million, with the most recent change of +$6.31 million (+5.32%) on September 30, 2025.
  • Over the past year, TARS quarterly operating expenses has increased by +$54.88 million (+78.36%).
  • TARS quarterly operating expenses is now at all-time high.

Performance

TARS Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSincome statement metrics

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

TARS Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+82.8%+78.4%
3Y3 Years+333.2%+450.4%
5Y5 Years+6663.5%+1141.6%

TARS Operating Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+333.2%at high+450.4%
5Y5-Yearat high+6663.5%at high+1141.6%
All-TimeAll-Timeat high>+9999.0%at high>+9999.0%

TARS Operating Expenses History

DateAnnualQuarterly
Sep 2025
-
$124.92M(+5.3%)
Jun 2025
-
$118.61M(+19.3%)
Mar 2025
-
$99.40M(+15.7%)
Dec 2024
$290.70M(+82.8%)
$85.90M(+22.7%)
Sep 2024
-
$70.04M(-1.5%)
Jun 2024
-
$71.11M(+11.7%)
Mar 2024
-
$63.64M(+13.0%)
Dec 2023
$159.01M(+81.6%)
$56.31M(+33.9%)
Sep 2023
-
$42.06M(+29.4%)
Jun 2023
-
$32.51M(+19.5%)
Mar 2023
-
$27.20M(+10.3%)
Dec 2022
$87.57M
$24.66M(+8.7%)
DateAnnualQuarterly
Sep 2022
-
$22.70M(+13.6%)
Jun 2022
-
$19.98M(+0.5%)
Mar 2022
-
$19.87M(+37.3%)
Dec 2021
$67.11M(+148.6%)
$14.47M(-13.7%)
Sep 2021
-
$16.76M(+19.8%)
Jun 2021
-
$14.00M(-34.7%)
Mar 2021
-
$21.42M(+88.5%)
Dec 2020
$27.00M(+528.2%)
$11.37M(+13.0%)
Sep 2020
-
$10.06M(+381.2%)
Mar 2020
-
$2.09M(+241.1%)
Dec 2019
$4.30M(+218.4%)
-
Sep 2019
-
$613.00K
Dec 2018
$1.35M
-

FAQ

  • What is Tarsus Pharmaceuticals, Inc. annual total operating expenses?
  • What is the all-time high annual operating expenses for Tarsus Pharmaceuticals, Inc.?
  • What is Tarsus Pharmaceuticals, Inc. annual operating expenses year-on-year change?
  • What is Tarsus Pharmaceuticals, Inc. quarterly total operating expenses?
  • What is the all-time high quarterly operating expenses for Tarsus Pharmaceuticals, Inc.?
  • What is Tarsus Pharmaceuticals, Inc. quarterly operating expenses year-on-year change?

What is Tarsus Pharmaceuticals, Inc. annual total operating expenses?

The current annual operating expenses of TARS is $290.70M

What is the all-time high annual operating expenses for Tarsus Pharmaceuticals, Inc.?

Tarsus Pharmaceuticals, Inc. all-time high annual total operating expenses is $290.70M

What is Tarsus Pharmaceuticals, Inc. annual operating expenses year-on-year change?

Over the past year, TARS annual total operating expenses has changed by +$131.68M (+82.81%)

What is Tarsus Pharmaceuticals, Inc. quarterly total operating expenses?

The current quarterly operating expenses of TARS is $124.92M

What is the all-time high quarterly operating expenses for Tarsus Pharmaceuticals, Inc.?

Tarsus Pharmaceuticals, Inc. all-time high quarterly total operating expenses is $124.92M

What is Tarsus Pharmaceuticals, Inc. quarterly operating expenses year-on-year change?

Over the past year, TARS quarterly total operating expenses has changed by +$54.88M (+78.36%)
On this page